Investor group to sell Asthmatx to Boston Scientific – Trading Markets (press release)


Daily Rosetta

Investor group to sell Asthmatx to Boston Scientific
Trading Markets (press release)
The addition of Asthmatx's products will allow Boston Scientific to expand its reach to patients suffering the effects of severe asthma.
Boston Scientific to Acquire AsthmatxPR Newswire (press release)
Boston Scientific Corporation To Buy Asthmatx Inc. For US$443 MillionMedical News Today
Boston Scientific Locks Down Asthma Co Asthmatx For $443.5 Mln (BSX)Comtex Smartrend
domain-B –The Associated Press –Motley Fool
all 146 news articles »

View full post on asthma – Google News

Boston Scientific to Acquire Asthmatx – PR Newswire (press release)


Daily Rosetta

Boston Scientific to Acquire Asthmatx
PR Newswire (press release)
Asthmatx designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma in
Boston Scientific Corporation To Buy Asthmatx Inc. For US$443 MillionMedical News Today
Boston Scientific to buy Asthmatx for $193.5 milliondomain-B
Boston Scientific Locks Down Asthma Co Asthmatx For $443.5 Mln (BSX)Comtex Smartrend
The Associated Press –Motley Fool –RTT News
all 146 news articles »

View full post on asthma – Google News

Quality of care gets better in US hospitals – Healthcare Digital (press release)


WTNH

Quality of care gets better in US hospitals
Healthcare Digital (press release)
As per a report, treatment in US hospitals for ailments like heart attacks, pneumonia and children's asthma has enhanced. The report, which as released on
Quality of care up at US hospitals, report saysThe Associated Press
Joint Commission Annual Report Shows Big Improvements for Hospital CareMarketwire (press release)
US Hospitals Get Better at Treating Heart Attacks, PneumoniaDailyFinance

all 245 news articles »

View full post on asthma – Google News

GSK and Theravance announce combination ICS/LABA Phase II results in the … – MarketWatch (press release)

GSK and Theravance announce combination ICS/LABA Phase II results in the
MarketWatch (press release)
Our ongoing collaboration with GSK includes the Phase III programmes in both COPD and asthma, which are already underway for Relovair and its components.
Theravance Announces Results From Phase II Study For Developmental Combination Stock Markets Review

all 10 news articles »

View full post on asthma – Google News

CGC: MEDA: Helpful and supportive tool for asthma therapy – DOs and DON’Ts of … – Reuters (press release)

CGC: MEDA: Helpful and supportive tool for asthma therapy – DOs and DON'Ts of
Reuters (press release)
One in four asthma patients sought emergency treatment for symptomatic asthma during the last year and as many as 16% of asthma patients still use a rescue
MEDA: Helpful and supportive tool for asthma therapy – DOs and DON'Ts of using CisionWire (press release)

all 3 news articles »

View full post on asthma – Google News